Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database.

Zreik, Jad; Kerezoudis, Panagiotis; Alvi, Mohammed Ali; Yolcu, Yagiz U; Kizilbash, Sani H

Zreik, Jad; Kerezoudis, Panagiotis; Alvi, Mohammed Ali; Yolcu, Yagiz U; Kizilbash, Sani H.

Afiliación

Zreik J; College of Medicine, Central Michigan University, Mount Pleasant, MI, United States.
Kerezoudis P; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
Alvi MA; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
Yolcu YU; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
Kizilbash SH; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.

Front Oncol ; 11: 746844, 2021.

Article en En | MEDLINE | ID: mdl-34858822

Palabras clave

1p/19q codeletion; adjuvant treatment; disparities; molecular testing; oligoastrocytoma; oligodendroglioma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article